PEOPLE - Enpath Medical makes appointment:
This article was originally published in Clinica
Scott Youngstrom has been named as CFO of percutaneous delivery systems specialist Enpath Medical (Plymouth, Minnesota). He replaces James Hartman, who stepped down in January, but who will continue as chairman of the board of directors. Mr Youngstrom, who has 20 years of financial experience in the medtech industry, joins from Compex Technologies (electronic muscle stimulation devices), where he was president and CFO.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.